U.S. News & World Report Names Jupiter Medical Center a High Performing Hospital for Stroke, Colon Cancer Surgery, Lung Cancer Surgery, Kidney Failure and COPD

U.S. News & World Report, the trusted source in hospital rankings and consumer advice, has named Jupiter Medical Center a 2022-2023 High Performing hospital for Stroke, Colon Cancer Surgery, Lung Cancer Surgery, Kidney Failure and COPD. This is the highest award a hospital can earn for U.S. News’ Best Hospitals Procedures & Conditions ratings.

The annual Procedures & Conditions ratings are designed to assist patients and their doctors in making informed decisions about where to receive care for challenging health conditions or elective procedures.

“The recognition from U.S. News & World Report is a tremendous accomplishment for Jupiter Medical Center,” says Amit Rastogi, MD, MHCM, President and CEO of Jupiter Medical Center. “Our world-class caregivers consistently provide our patients with exceptional outcomes, and with our recent expansion news and UF Health partnership announcement, will soon be able to do even more. Our entire team of healthcare experts is unwavering in its commitment to providing the highest quality of care to our growing region.”

Earlier this year Jupiter Medical Center revealed plans for its new Surgical Institute. The 90,000-square-foot space is slated to open in 2023 with 16 state-of-the-art operating rooms and two hybrid rooms in a dedicated facility. Additionally, the independent, not-for-profit hospital system recently announced a partnership with UF Health to advance the organizations’ complementary missions of providing the best of academic and community medicine. Among other highlights, the partnership could also open up fast access to a large array of clinical trials.

For the 2022-2023 Best Hospitals rankings and ratings, U.S. News evaluated more than 4,500 hospitals across 15 specialties and 20 procedures and conditions.

“When patients are considering their options for care, the Best Hospitals ratings are designed to help them identify hospitals that excel in the kind of care they may need,” said Ben Harder, chief of health analysis and managing editor at U.S. News. “A hospital that’s earned a High Performing rating in a service may be a good option for patients in need of that service and their medical professionals to consider.”

The U.S. News Procedures & Conditions methodology is based entirely on objective measures of quality such as survival rates, patient experience, and how successfully each hospital helps patients get back home.

Hot this week

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.